enVVeno Medical Corp expected to post a loss of 46 cents a share - Earnings Preview

enVVeno Medical

13/02/2024 22:21

* enVVeno Medical Corp  NVNO.OQ   NVNO.O  is expected
to show no
change in quarterly revenue when it reports  results on February
15 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for enVVeno Medical Corp is
for a
loss of 46 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for enVVeno
Medical
Corp is $20.40​, above​ its last closing price of $4.85. ​​​

This summary was machine generated February 13 at 22:21 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)